Free tool
FAERS Monitor: Ambien Cr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021774 or its brand name (Ambien Cr, Zolpidem Tartrate). Reports on generic versions are filed under their own applications.
Reports
86,212
Serious
54,394
63% of reports
Hospitalization
26,627
Death reported
7,465
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea6,141
- drug ineffective6,033
- fatigue5,990
- insomnia4,866
- pain4,780
- headache4,552
- diarrhoea4,179
- anxiety3,977
- dizziness3,837
- dyspnoea3,743
- fall3,684
- depression3,442
- vomiting3,400
- asthenia3,195
- arthralgia2,684
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,922 |
| 2005 | 2,500 |
| 2006 | 3,322 |
| 2007 | 3,220 |
| 2008 | 2,649 |
| 2009 | 3,416 |
| 2010 | 3,965 |
| 2011 | 3,704 |
| 2012 | 4,791 |
| 2013 | 3,999 |
| 2014 | 3,972 |
| 2015 | 6,134 |
| 2016 | 6,652 |
| 2017 | 4,956 |
| 2018 | 6,106 |
| 2019 | 4,674 |
| 2020 | 3,851 |
| 2021 | 2,891 |
| 2022 | 2,989 |
| 2023 | 2,726 |
| 2024 | 2,810 |
| 2025 | 2,867 |
| 2026 | 2,091 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,967,947 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| insomniaSignal | 4,866 | 4.5 | 4.4 | 13,266 |
| depressionSignal | 3,442 | 3.7 | 3.6 | 6,851 |
| anxietySignal | 3,977 | 3.4 | 3.3 | 6,890 |
| fallSignal | 3,684 | 2.7 | 2.6 | 4,023 |
| astheniaSignal | 3,195 | 2.1 | 2.0 | 1,813 |
| pain | 4,780 | 1.9 | 1.9 | 2,101 |
| nausea | 6,141 | 1.9 | 1.9 | 2,698 |
| fatigue | 5,990 | 1.9 | 1.8 | 2,559 |
| dizziness | 3,837 | 1.9 | 1.8 | 1,616 |
| headache | 4,552 | 1.8 | 1.7 | 1,582 |
| vomiting | 3,400 | 1.8 | 1.7 | 1,155 |
| dyspnoea | 3,743 | 1.6 | 1.6 | 899 |
| diarrhoea | 4,179 | 1.6 | 1.5 | 920 |
| arthralgia | 2,684 | 1.6 | 1.5 | 576 |
| drug ineffective | 6,033 | 1.1 | 1.1 | 79 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.